Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolysis for acute stroke.

P D Lyden1

  • 1Veteran's Affairs Medical Center and the UCSD Stroke Center, San Diego, CA 92103-8466, USA.

Progress in Cardiovascular Diseases
|December 22, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultra-rapid identification, triage, and enrollment of stroke patients into clinical trials.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Protease activated receptor-1 mediates cytotoxicity during ischemia using in vivo and in vitro models.

Neuroscience·2014
Same author

Anti-adrenergic medications and edema development after intracerebral hemorrhage.

Neurocritical care·2011
Same author

Production and validation of Putonghua- and Cantonese-Chinese language National Institutes of Health Stroke Scale training and certification videos.

International journal of stroke : official journal of the International Stroke Society·2010
Same author

The modified National Institutes of Health Stroke Scale: its time has come.

International journal of stroke : official journal of the International Stroke Society·2009
Same author

Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH.

Neurology·2009
Same journal

Multimodality imaging of vulnerable plaque: Are we there yet? A multifaceted perspective.

Progress in cardiovascular diseases·2026
Same journal

Beyond LDL-C: Triangulating residual risk via lipoprotein(a), remnant cholesterol, and vascular inflammation.

Progress in cardiovascular diseases·2026
Same journal

COVID-19 and coronary atherosclerosis: Unmasking and accelerating?

Progress in cardiovascular diseases·2026
Same journal

Mavacamten and left ventricular dysfunction in hypertrophic cardiomyopathy with left bundle branch block.

Progress in cardiovascular diseases·2026
Same journal

Lessons from ATTR-CM clinical trials: Progress, persistent disparities, and emerging treatment dilemmas.

Progress in cardiovascular diseases·2026
Same journal

Circulating microRNA signatures associated with atrial remodeling in endurance athletes with PAFIYAMA syndrome: A case-control study.

Progress in cardiovascular diseases·2026
See all related articles

Thrombolysis for acute stroke is effective when following protocols. This treatment is safe, beneficial for most patients, and cost-effective, though research for better options continues.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Acute stroke thrombolysis has been established as an effective treatment since 1995.
  • Subsequent studies have consistently confirmed its safety and efficacy.
  • No specific patient subgroups with a higher likelihood of benefit or hemorrhage have been identified at baseline.

Purpose of the Study:

  • To review the established efficacy and safety of thrombolysis for acute stroke.
  • To highlight the cost-effectiveness of this intervention.
  • To acknowledge the ongoing research for improved thrombolytic agents.

Main Methods:

  • Review of existing literature and clinical reports on thrombolysis for acute stroke.
  • Analysis of safety and efficacy data from published studies.

Related Experiment Videos

  • Assessment of economic impact and cost-effectiveness.

    • Main Results:

    • Thrombolysis administered per protocol is effective for acute stroke.
    • The treatment demonstrates a favorable safety profile with no identifiable high-risk subgroups at baseline.
    • Thrombolysis for acute stroke offers significant long-term cost savings to the healthcare system.

    Conclusions:

    • Thrombolysis is a proven, safe, and effective treatment for acute stroke.
    • The intervention is economically beneficial, reducing overall healthcare expenditures.
    • Continued research is essential to develop even safer and more effective thrombolytic therapies.